Eating behaviors in obese children with pseudohypoparathyroidism type 1a: a cross-sectional study

Lulu Wang, Ashley H Shoemaker, Lulu Wang, Ashley H Shoemaker

Abstract

Background: Children with pseudohypoparathyroidism type 1a (PHP-1a) develop early-onset obesity. These children have decreased resting energy expenditure but it is unknown if hyperphagia contributes to their obesity.

Methods: We conducted a survey assessment of patients 2 to 12 years old with PHP-1a and matched controls using the Hyperphagia Questionnaire (HQ) and Children's Eating Behavior Questionnaire (CEBQ). Results of the PHP-1a group were also compared with an obese control group and normal weight sibling group.

Results: We enrolled 10 patients with PHP-1a and 9 matched controls. There was not a significant difference between the PHP-1a group and matched controls for total HQ score (p = 0.72), Behavior (p = 0.91), Drive (p = 0.48) or Severity (p = 0.73) subset scores. There was also no difference between the PHP-1a group and matched controls on the CEBQ. In a secondary analysis, the PHP-1a group was compared with obese controls (n = 30) and normal weight siblings (n = 6). Caregivers reported an increased interest in food before age 2 years in 6 of 10 PHP-1a patients (60%), 9 of 30 obese controls (30%) and none of the siblings (p = 0.04). The sibling group had a significantly lower Positive Eating Behavior score than the PHP-1a group (2.6 [2.4, 2.9] vs. 3.5 [3.1, 4.0], p < 0.01) and obese controls (2.6 [2.4, 2.9] vs. 3.4 [2.6, 3.8], p = 0.04), but there was not a significant difference between the PHP-1a and obese controls (p = 0.35). The sibling group had a lower Desire to Drink score than both the PHP-1a group (1.8 [1.6, 2.7] vs. 4.3 [3.3, 5.0], p < 0.01) and obese controls (1.8 [1.6, 2.7] vs. 3.3 [3.0, 4.0], p < 0.01) but there was not a significant difference between the PHP-1a and obese control Desire to Drink scores (p = 0.11).

Conclusions: Patients with PHP-1a demonstrate hyperphagic symptoms similar to matched obese controls.

Keywords: Eating behaviors; Obesity; Pseudohypoparathyroidism.

Figures

Figure 1
Figure 1
Hyperphagia questionnaire scores, total and subset, in children with pseudohypoparathyroidism type 1a (PHP-1a, circles) and matched controls (squares). There was no significant difference between groups by Mann–Whitney U test (Total HQ score p = 0.72, Behavior p = 0.91, Drive p = 0.48 or Severity p = 0.73). Values shown are median ± interquartile range.
Figure 2
Figure 2
Hyperphagia questionnaire scores, total and subset, in children with pseudohypoparathyroidism type 1a (PHP-1a, circles), obese controls (squares) and siblings (triangles). There was no significant difference between groups by Kruskal Wallis test (Total HQ score p = 0.40, Behavior p = 0.60, Drive p = 0.31 or Severity p = 0.43). Values shown are median ± interquartile range.
Figure 3
Figure 3
Childhood eating behavior questionnaire positive eating behavior subset scores in children with pseudohypoparathyroidism type 1a (PHP-1a, circles) and matched controls (squares). There was no significant difference between groups by Mann–Whitney U test (Food Responsiveness p = 1.0, Enjoyment of Food p = 0.81, Emotional Overeating p = 0.73 and Desire to Drink p = 0.31). Values shown are median ± interquartile range.
Figure 4
Figure 4
Childhood eating behavior questionnaire positive eating behavior subset scores in children with pseudohypoparathyroidism type 1a (PHP-1a, circles), obese controls (squares) and siblings (triangles). Values shown are median ± interquartile range. *Indicates p value <0.05 by Mann–Whitney U test following a significant Kruskal-Wallis test.

References

    1. Chen M, Gavrilova O, Liu J, Xie T, Deng C, Nguyen AT, Nackers LM, Lorenzo J, Shen L, Weinstein LS. Alternative Gnas gene products have opposite effects on glucose and lipid metabolism. Proc Natl Acad Sci U S A. 2005;102:7386–7391. doi: 10.1073/pnas.0408268102.
    1. Chen M, Wang J, Dickerson KE, Kelleher J, Xie T, Gupta D, Lai EW, Pacak K, Gavrilova O, Weinstein LS. Central nervous system imprinting of the G protein G(s)alpha and its role in metabolic regulation. Cell Metab. 2009;9:548–555. doi: 10.1016/j.cmet.2009.05.004.
    1. Germain-Lee EL, Schwindinger W, Crane JL, Zewdu R, Zweifel LS, Wand G, Huso DL, Saji M, Ringel MD, Levine MA. A mouse model of albright hereditary osteodystrophy generated by targeted disruption of exon 1 of the Gnas gene. Endocrinology. 2005;146:4697–4709. doi: 10.1210/en.2005-0681.
    1. Long DN, McGuire S, Levine MA, Weinstein LS, Germain-Lee EL. Body mass index differences in pseudohypoparathyroidism type 1a versus pseudopseudohypoparathyroidism may implicate paternal imprinting of Galpha(s) in the development of human obesity. J Clin Endocrinol Metab. 2007;92:1073–1079. doi: 10.1210/jc.2006-1497.
    1. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med. 2003;348:1085–1095. doi: 10.1056/NEJMoa022050.
    1. Shoemaker AH, Lomenick JP, Saville BR, Wang W, Buchowski MS, Cone RD. Energy expenditure in obese children with pseudohypoparathyroidism type 1a. Int J Obes (Lond) 2012;37:1147–1153.
    1. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 1997;88:131–141. doi: 10.1016/S0092-8674(00)81865-6.
    1. Dykens EM, Maxwell MA, Pantino E, Kossler R, Roof E. Assessment of hyperphagia in Prader-Willi syndrome. Obesity. 2007;15:1816–1826. doi: 10.1038/oby.2007.216.
    1. Wardle J, Guthrie CA, Sanderson S, Rapoport L. Development of the children’s eating behaviour questionnaire. J Child Psychol Psychiatry. 2001;42:963–970. doi: 10.1111/1469-7610.00792.
    1. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–381. doi: 10.1016/j.jbi.2008.08.010.
    1. Valette M, Bellisle F, Carette C, Poitou C, Dubern B, Paradis G, Hercberg S, Muzard L, Clement K, Czernichow S. Eating behaviour in obese patients with melanocortin-4 receptor mutations: a literature review. Int J Obes (Lond) 2013;37:1027–1035. doi: 10.1038/ijo.2012.169.
    1. Muniyappa R, Warren MA, Zhao X, Aney SC, Courville AB, Chen KY, Brychta RJ, Germain-Lee EL, Weinstein LS, Skarulis MC. Reduced insulin sensitivity in adults with pseudohypoparathyroidism type 1a. J Clin Endocrinol Metab. 2013;98:E1796–E1801. doi: 10.1210/jc.2013-1594.
    1. Ong KK, Amin R, Dunger DB. Pseudohypoparathyroidism–another monogenic obesity syndrome. Clin Endocrinol (Oxf) 2000;52:389–391. doi: 10.1046/j.1365-2265.2000.00911.x.
    1. Han JC, Liu QR, Jones M, Levinn RL, Menzie CM, Jefferson-George KS, Adler-Wailes DC, Sanford EL, Lacbawan FL, Uhl GR, Rennert OM, Yanovski JA. Brain-derived neurotrophic factor and obesity in the WAGR syndrome. N Engl J Med. 2008;359:918–927. doi: 10.1056/NEJMoa0801119.
    1. Sherafat-Kazemzadeh R, Ivey L, Kahn SR, Sapp JC, Hicks MD, Kim RC, Krause AJ. Hyperphagia in Patients with Bardet Biedl Syndrome. Pediatric Academic Societies Annual Meeting; Washington, D.C. 2013.
    1. Seo S, Guo DF, Bugge K, Morgan DA, Rahmouni K, Sheffield VC. Requirement of Bardet-Biedl syndrome proteins for leptin receptor signaling. Hum Mol Genet. 2009;18:1323–1331. doi: 10.1093/hmg/ddp031.
    1. Rahmouni K, Fath MA, Seo S, Thedens DR, Berry CJ, Weiss R, Nishimura DY, Sheffield VC. Leptin resistance contributes to obesity and hypertension in mouse models of Bardet-Biedl syndrome. J Clin Invest. 2008;118:1458–1467. doi: 10.1172/JCI32357.
    1. Fox EA, Byerly MS. A mechanism underlying mature-onset obesity: evidence from the hyperphagic phenotype of brain-derived neurotrophic factor mutants. Am J Physiol Regul Integr Comp Physiol. 2004;286:R994–R1004. doi: 10.1152/ajpregu.00727.2003.
    1. Sweetman C, Wardle J, Cooke L. Soft drinks and ‘desire to drink’ in preschoolers. Int J Behav Nutr Phys Act. 2008;5:60. doi: 10.1186/1479-5868-5-60.
    1. de Ruyter JC, Olthof MR, Seidell JC, Katan MB. A trial of sugar-free or sugar-sweetened beverages and body weight in children. N Engl J Med. 2012;367:1397–1406. doi: 10.1056/NEJMoa1203034.
    1. Ebbeling CB, Feldman HA, Chomitz VR, Antonelli TA, Gortmaker SL, Osganian SK, Ludwig DS. A randomized trial of sugar-sweetened beverages and adolescent body weight. N Engl J Med. 2012;367:1407–1416. doi: 10.1056/NEJMoa1203388.

Source: PubMed

3
Prenumerera